Patent ID: 11890325
Assignee: ELI LILLY AND COMPANY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 1:
2. The method of claim 1, wherein the cardiovascular risk factors are selected from the group consisting of (a), (b), (c), (d) and (e):
(a) tobacco use;
(b) at least 1 of:
i) use of at least 1 approved lipid modifying therapy to treat hypercholesterolemia; or
ii) a documented untreated low-density lipoprotein cholesterol (LDL-C) ≥3.4 mmol/L (130 mg/dL) within the past 6 months;

(c) at least 1 of:
i) high-density lipoprotein cholesterol (HDL-C) measurement within the past 6 months of: <1.0 mmol/L (40 mg/dL) for men; and <1.3 mmol/L (50 mg/dL) for women; or
ii) triglycerides ≥2.3 mmol/L (200 mg/dL) within the past 6 months;

d) at least 1 of:
i) use of at least 1 blood pressure medication to treat hypertension; or
ii) untreated systolic blood pressure (SBP) ≥140 mm Hg or diastolic blood pressure (DBP) ≥95 mmHg; and

(e) measured waist-to-hip ratio >1.0 for men and >0.8 for women.